National and Kapodistrian University of Athens
ΜΑΚΡΟΧΡΟΝΙΟΣ ΧΟΡΗΓΗΣΙΣ ΥΨΗΛΩΝ ΔΟΣΕΩΝ ΟΞΕΙΚΗΣ ΜΕΔΡΟΞΥ - ΠΡΟΓΕΣΤΕΡΟΝΗΣ ΕΙΣ ΑΣΘΕΝΕΙΣ ΜΕ ΓΕΝΙΚΕΥΜΕΝΟΝ ΚΑΡΚΙΝΟΝ ΤΟΥ ΜΑΣΤΟΥ
Abstract
dc:descriptionHIGH DOSES OF MEDROXYPROGESTERONE ACETATE WERE ADMINISTERED TO 42 PATIENTS (39WOMEN AND 3 MEN) WITH ADVANCED BREAST CANCER. THE DOSAGE SCHEDULE WAS 500 MG I.M. DAILY FOR 90 CONCECUTIVE DAYS, FOLLOWED BY RANDOMIZATION TO TWO ARMS. HALFOF THE PATIENTS RECEIVED 500 MG IM TWICE WEEKLY AND HALF 500 MG PER OS DAILY. TWENTY - THREE OUT OF 42 PATIENTS (54,76%) OBTAINED A COMPLETE OR PARTIAL REMISSION. THE MEAN DURATION OF REMISSION WAS (5 - 6) MONTHS. PATIENTS WITH SOFT TISSUE DISEASE HAD THE BEST RESPONSE RATE (63,5%) FOLLOWED BY PATIENTS WITH OSSEUS DISEASE (52%) AND PATIENTS WITH PULMONARY DISEASE (40%). POSTMENOPAMAL PATIENTS AND PATIENTS WITH FREE INTERVAL MORE THAN 1 YEARS SHOWED THE HIGHEST RESPONSE RATE. THE RESPONSE RATE OF PATIENTS RESISTANT TO STANDARD CHEMOTHERAPY AND/OR HORMONE THERAPY WAS 51.5. PAIN RELIEF WAS NOTED IN 69% OF THE CASES. IN MOST CASES THERE WAS AN IMPROVEMENT OF THE PERFORMANCE STATUS. SIDE - EFFECTS WERE NOTED IN 52% OF THE CASES BUT THERE WERE ALWAYS REVERSIBLE. THE MOST SIGNIFICANT SIDE - EFFECTS WERE BODY WEIGHT GAIN AND MOON - FACE. THE MOST INTERESTING SIDE - EFFECT WAS THE APPEARANCE OF DIABETES MALLITS OR DEREGULATION OF PRE - EXISTING DIABETES MELLITUS. IN NO CASE TREATMENT WAS DISCONTINNUED BECAUSE OF SIDE - EFFECTS.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 1981
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Σταμογιάννου, Λέλα
Subjects
dc:subject × 4Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/8394